Bulletin
Investor Alert

Market Pulse Archives

Sept. 19, 2022, 11:31 a.m. EDT

Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Moderna Inc. (MRNA)
  • X
    Pfizer Inc. (PFE)
  • X
    BioNTech SE ADR (BNTX)

or Cancel Already have a watchlist? Log In

By Ciara Linnane

Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with "60 Minutes" that aired on Sunday. Moderna Inc. /zigman2/quotes/205619834/composite MRNA -0.23% fell 9.2%, Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.74% was down 1.7% and its German partner BioNTech SE /zigman2/quotes/214419716/composite BNTX -0.88% was down 8.4%. Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.88% , which had its protein-based vaccine authorized in July, was last down 9%. The SPDR S&P Biotech ETF /zigman2/quotes/205950134/composite XBI +0.07% was down 2.2%.

/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 176.40
-0.41 -0.23%
Volume: 1.22M
Nov. 25, 2022 1:00p
P/E Ratio
6.38
Dividend Yield
N/A
Market Cap
$67.77 billion
Rev. per Employee
$7.86M
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 49.21
+0.36 +0.74%
Volume: 6.76M
Nov. 25, 2022 1:10p
P/E Ratio
9.48
Dividend Yield
3.25%
Market Cap
$276.23 billion
Rev. per Employee
$1.26M
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 154.85
-1.38 -0.88%
Volume: 348,316
Nov. 25, 2022 1:00p
P/E Ratio
3.46
Dividend Yield
0.00%
Market Cap
$37.58 billion
Rev. per Employee
$6.61M
loading...
/zigman2/quotes/202614340/composite
US : U.S.: Nasdaq
$ 16.54
-0.49 -2.88%
Volume: 2.11M
Nov. 25, 2022 1:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.30 billion
Rev. per Employee
$1.13M
loading...
/zigman2/quotes/205950134/composite
US : U.S.: NYSE Arca
$ 81.06
+0.06 +0.07%
Volume: 2.70M
Nov. 25, 2022 1:10p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.